| Also known as |
Enalapril maleate |
| Blood pressure |
Reduces systolic and diastolic blood pressure |
| Chemical name |
(2S)-1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline, dihydrate |
| Dosage (medical) |
Typically starts at 5 mg once daily, adjusted as needed |
| Dosage (sports) |
Not applicable |
| Effects |
Reduction in blood pressure, improved heart function |
| Formula |
C20H28N2O5В·2H2O |
| Half-life |
Approximately 11 hours |
| Hepatotoxicity |
Rare hepatotoxic effects |
| Lab Test |
Monitoring of serum potassium and renal function recommended |
| Main action |
Lowers blood pressure by inhibiting the conversion of angiotensin I to angiotensin II |
| Side effects |
Cough, hypotension, dizziness, headache, fatigue |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Strength |
2.5 MG |
| Substance class |
Angiotensin-converting enzyme (ACE) inhibitor |
| Trade name |
Vasotec, Renitec, Enacard |
| Use in sports |
Not typically used in sports |
| Water Retention |
Low risk of water retention |
| Manufacturer |
Intas Pharmaceuticals |
